Document:

aspn-ex101_240.htm

 

Exhibit 10.1

First Addendum to the Amended and Restated Supply Agreement

This first addendum (“First Addendum”) to the Amended and Restated Supply Agreement dated February 16, 2018 (the “AR Agreement”) between BASF Polyurethanes GmbH, with a principal place of business at Elastogranstralβe 60, 49443 Lemforde, Germany (“BASF”) and Aspen Aerogels, Inc., with a principal place of business at 30 Forbes Road, Building B, Northborough, Massachusetts, 01532, USA (“ASPEN”) concerning supply of Products by ASPEN to BASF is effective as of the latest date set forth in the signature block below. Capitalized terms used herein that are not otherwise defined below, have the meanings ascribed to them in the AR Agreement.

WHEREAS, ASPEN and BASF's parent, BASF SE have entered into a Joint Development Agreement dated June 21, 2016 (“JDA”) and a Project Charter dated March 1, 2017 (“Charter”) pursuant to which a [***] product has been developed;

WHEREAS, BASF SE and ASPEN are also engaged in the negotiation of the terms and conditions under which BASF or its parent, BASF SE and ASPEN may commercialize Developed Product, which terms and conditions may include [***] between ASPEN and BASF or their Affiliates;

WHEREAS, the Parties desire that ASPEN manufacture and supply to BASF and BASF provide samples of Developed Product to targeted customers in a [***] BASF desires that ASPEN reconfigure ASPEN's facility to manufacture Developed Product in agreed quantities and supply to BASF through [***];

WHEREAS, ASPEN and BASF have agreed to negotiate in good faith to commercialize Developed Product pursuant to and as contemplated in Section 9 of the Charter and Sections 3.8, 3.9 and 4.2 of the JDA including a potential investment in [***];

WHEREAS, the Parties desire to amend the AR Agreement to incorporate Developed Product as an additional Product to be supplied under that agreement, to agree on another Pre-Payment Tranche to support Aspen's efforts to supply Developed Products in the agreed quantities hereunder and to establish conditions related to repayment of the same;

NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

	
1.
	
Definitions:  The following terms shall be added to the Definitions section of the AR Agreement:

	
 
	
“Developed Product”
	
[***] product meeting the specification attached to this First Addendum as Annex 2.

 

	
 
	
“Total Volume Range”
	
in connection with Developed Product shall mean the [***] and thereafter.

	
 
	
“[***] Markets”
	
shall have the meaning as defined in Annex 1 hereto.

	
 
	
“Pre-Commercialization Period” 
	
shall have the meaning described in the first sentence of Section 4 below.

[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.

 

 

 

 

	
2.
	
Developed Product shall be deemed a new product for purposes of the AR Agreement. ASPEN shall deliver Developed Product to BASF up to Total Volume Range in the applicable calendar year. The price of such Developed Product shall be the sum of (i) [***], plus (ii) [***] subject to change as of the date of this First Addendum. Specification may also be changed. Parties shall negotiate in good faith, any modifications to this Addendum to minimize, to the extent possible, any adverse impact of such changes on manufacturing and related costs.

	
3.
	
The Parties acknowledge that [***]supported by Pre-Payment Tranches that impact the efficiency of the current production process for Spaceloft A2 may reduce the Standard Cost of Spaceloft A2. Pursuant to the Side Agreement for Spaceloft A2, a reduction in Standard Cost of Spaceloft A2 will result in a reduction in the price of Spaceloft A2. The Parties are targeting a reduction in the cost of Spaceloft A2 by [***].

	
4.
	
For a period from effective date hereof until [***], BASF shall use the Developed Product supplied hereunder to sell, supply and assess demand in the [***] Markets whereby ASPEN shall use Developed Product to sell, supply and assess demand in markets other than the [***] Markets (“Pre-Commercialization Period”). . During the Pre-Commercialization Period Parties shall share demand assessments with each other to advance commercialization negotiations and shall negotiate the terms and conditions of the commercialization of Developed Product as set forth in Section 9 of the Charter and Section 3.8 of the JDA (“TERMS”). At the end of the Pre-Commercialization Period, if the Parties in good faith are unable to agree to the TERMS, the provisions of Section 3.9 and 4.2 of the JDA shall apply. The mutual exclusivity described in the first sentence of this Section 4 shall replace any exclusivity arising from Section 1.1 of AR Agreement with respect to Developed Product.

	
5.
	
Aspen shall provide a certificate of analysis to BASF on the properties tested on Developed Product shipped to BASF to ensure that the regularly tested properties comply with their respective requirements in the product specifications as in Annex 2;

	
6.
	
The AR Agreement shall be extended, only with respect to Developed Product, until [***]. However, nothing in this First Addendum shall change the terms of the AR Agreement with respect to any other Product, and with respect to SPACELOFT A2, except to the extent as expressly provided in Section 7(4) below.

	
7.
	
A new subsection E shall be added as an amendment to Annex 4 satisfying the obligations of Annex 4, Section C as follows:

E. Pre-Payment Tranche 2

(1)BASF will remit to ASPEN by wire transfer five million U.S dollars ($5,000,000) no later than January 31, 2019.

(2)The Target Date with respect to Pre-Payment Tranche 2 shall be December 31, 2022.

(3)After January 1, 2020, ASPEN will credit up to fifty percent (50%) of any amounts invoiced by ASPEN for Developed Product sold and delivered to BASF pursuant to this First Addendum against the available Pre-Payment Balance originating from this Pre-Payment Tranche 2.

[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.

 

 

 

 

 

 

 

(4)If, as of the Target Date, credits associated with the sale and delivery of Developed Products have not fully covered the value of Pre-Payment Tranche 2, BASF may upon its sole discretion request, as an alternative to the credit set forth in E. (3) above or the repayment set forth in E. (5) below, that ASPEN instead credit 24.7% of any amounts invoiced by ASPEN for SPACELOFT A2 against the available Pre-Payment Balance from this Pre-Payment Tranche 2 (“Alternative Credit”). The Alternative Credit shall be in addition to credits available on amounts invoiced by ASPEN for SPACELOFT A2, if any, associated with Pre-Payment Tranche 1.

(5)As set forth in Section 5.2 of the AR Agreement, BASF may alternatively request, upon six weeks prior written notice, from ASPEN the repayment of the remainder of the available Pre-Payment Balance from this Pre-Payment Tranche 2, if any, at any time at or after the Target Date.

(6)The Pre-Payment Balance from this Pre-Payment Tranche 2 may be repaid by ASPEN to BASF at any time in whole or in part and for any reason.

	
8.
	
This First Addendum is intended by the Parties to be an amendment meeting the requirements of Section 13.1 of the AR Agreement.

	
9.
	
Nothing in this First Addendum modifies AR Agreement with respect to supply of SPACELOFT A2 except with respect to Alternative Credit; and Parties expect supply of SPACELOFT A2 and Developed Product to occur in parallel, as necessary.

IN WITNESS WHEREOF, the parties have executed this First Addendum as of the dates set forth below.

			
	
ASPEN AEROGELS, INC.

/s/ Donald R. Young
	
BASF POLYURETHANES GMBH

[***]
	
 

[***]

	
Name:  Donald R. Young
	
Name:  [***]
	
Name:  [***]

	
Title: President & CEO 
	
Title:  [***]
	
Title:  [***]

	
Date:  Jan 14 2019
	
Date:  11.1.2019
	
Date:  10.01.2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.

 

 

 

 

Annex 1— [***] Markets

Market definitions are aligned to and based on categorization of markets set forth [***] as of [***].

[***] Markets will be limited strictly to those markets specifically identified as approved below. Parties, upon mutual consent, make any additions or modifications to [***] Markets after the date hereof in writing.

1.[***]

2.[***].

3.[***].

4.[***].

[***].

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.

 

 

 

 

Annex 2 - SPECIFICATION FOR DEVELOPED PRODUCT

[***]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.aspn-ex102_43.htm

Exhibit 10.2

 

NINTH Amendment

to 

AMENDED AND RESTATED Loan and security agreement

 

This Ninth Amendment to Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into this 4th day of March, 2019 by and between SILICON VALLEY BANK (“Bank”) and ASPEN AEROGELS, INC., a Delaware corporation (“Borrower”) whose address is 30 Forbes Road, Building B, Northborough, Massachusetts 01532.

Recitals

A.Bank and Borrower have entered into that certain Amended and Restated Loan and Security Agreement dated as of September 3, 2014, as amended by that certain Consent and First Amendment to Amended and Restated Loan and Security Agreement dated as of August 19, 2016, as further amended by that certain Second Amendment to Amended and Restated Loan and Security Agreement dated as of November 23, 2016, as further amended by that certain Third Amendment to Amended and Restated Loan and Security Agreement dated as of December 29, 2016, as further amended by that certain Fourth Amendment to Amended and Restated Loan and Security Agreement dated as of January 27, 2017, as further amended by that certain Fifth Amendment to Amended and Restated Loan and Security Agreement dated as of September 27, 2017, as further amended by that certain Consent and Sixth Amendment to Amended and Restated Loan and Security Agreement dated as of January 25, 2018, as further amended by that certain Seventh Amendment to Amended and Restated Loan and Security Agreement dated as of April 25, 2018, and as further amended by that certain Eighth Amendment to Amended and Restated Loan and Security Agreement and First Amendment to Preemptive Forbearance and Conditional Waiver Agreement dated as of November 30, 2018 (as amended, and as the same may from time to time be further amended, restated, amended and restated, modified and/or supplemented, the “Loan Agreement”).  

B.Bank and Borrower are party to that certain Preemptive Forbearance and Conditional Waiver Agreement dated as of May 31, 2018 (the “May Conditional Waiver”).

C.Bank and Borrower are party to that certain Preemptive Forbearance and Conditional Waiver Agreement dated as of August 30, 2018, as amended by that certain Eighth Amendment to Amended and Restated Loan and Security Agreement and First Amendment to Preemptive Forbearance and Conditional Waiver Agreement dated as of November 30, 2018, and as further amended by that certain Second Amendment to Preemptive Forbearance and Conditional Waiver Agreement dated as of December 28, 2018 (as amended, and as the same may from time to time be further amended, restated, amended and restated, modified and/or supplemented, the “August Conditional Waiver” and, together with the May Conditional Waiver, the “Conditional Waivers”).

D.Bank has extended credit to Borrower for the purposes permitted in the Loan Agreement.  

E.Borrower has requested that Bank amend the Loan Agreement to make certain revisions to the Loan Agreement as more fully set forth herein.

F.Bank has agreed to so amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and warranties set forth below.

Agreement

Now, Therefore, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

	
1.
	
Definitions.  Capitalized terms used but not defined in this Amendment shall have the meanings 

 

 

		
given to them in the Loan Agreement.

	
2.
	
Amendments to Loan Agreement.

2.1Section 3.4(a) (Procedures for Borrowing).  Subsection (a) of Section 3.4 is amended in its entirety and replaced with the following:

“(a)Subject to the prior satisfaction of all other applicable conditions to the making of an Advance set forth in this Agreement, an Advance shall be made upon Borrower’s irrevocable written notice delivered to Bank in the form of a Notice of Borrowing or without instructions if any Advances is necessary to meet Obligations which have become due, and such Notice of Borrowing shall indicate whether Borrower is requesting an Advance with respect to Eligible Accounts or Eligible Foreign Accounts, as applicable.  The Notice of Borrowing shall be made by Borrower through Bank’s online banking program, provided, however, if Borrower is not utilizing Bank’s online banking program, then such Notice of Borrowing shall be in the form attached hereto as Exhibit C and shall be executed by an Authorized Signer.  The Notice of Borrowing must be received by Bank prior to 12:00 p.m. Eastern time, (i) at least three (3) Business Days prior to the requested Funding Date, in the case of any LIBOR Advance, and (ii) on the requested Funding Date, in the case of a Prime Rate Advance, specifying: (1) the amount of the Advance; (2) the Currency in which such Advance shall be denominated; (3) the requested Funding Date; (4) whether the Advance is to be comprised of LIBOR Advances or Prime Rate Advances; and (5) the duration of the Interest Period applicable to any such LIBOR Advances included in such notice; provided that if the Notice of Borrowing shall fail to specify the duration of the Interest Period for any Advance comprised of LIBOR Advances, such Interest Period shall be one (1) month.  In addition to such Notice of Borrowing, when a Streamline Period is not in effect, Borrower must promptly deliver to Bank by electronic mail or through Bank’s online banking program such reports and information, including without limitation, sales journals, cash receipts journals, accounts receivable aging reports, as Bank may request in its sole discretion.”

 

2.2Section 5.3(c) (Accounts Receivable; Inventory).  Subsection (c) of Section 5.3 is deleted in its entirety and intentionally omitted.

2.3Section 6.2(b) (Financial Statements, Reports, Certificates).  Subsection (b) of Section 6.2 is amended in its entirety and replaced with the following:

“(b)within twenty (20) days after the end of each month, (A) monthly accounts receivable agings, aged by invoice date, (B) monthly accounts payable agings, aged by invoice date, and outstanding or held check registers, if any, and (C) monthly reconciliations of accounts receivable agings (aged by invoice date), transaction reports, Deferred Revenue report, and general ledger;”

 

2.4Section 6.9 (Financial Covenants).  Section 6.9 is amended in its entirety and replaced with the following:

“6.9Financial Covenant.  Borrower shall achieve, measured as of the end of each fiscal quarter during the following periods, EBITDA of at least (loss not worse than) the following for the following periods:

 

		
	
Period
	
Minimum EBITDA (maximum loss)

	
Trailing three (3) month period ending March 31, 2019
	
($4,500,000)

	
Trailing six (6) month period ending June 30, 2019
	
($5,000,000)

 

 

		
	
Trailing nine (9) month period ending September 30, 2019
	
($5,500,000)

	
Trailing twelve (12) month period ending December 31, 2019
	
($4,500,000)

 

2.5The contact information for the Bank’s counsel set forth in Section 10 is hereby amended in its entirety and replaced with the following:

“Morrison & Foerster LLP

200 Clarendon Street, 20th Floor

Boston, Massachusetts 02116

Attention: Charles W. Stavros, Esq.

Facsimile No.:(617) 830-0460

E-Mail: cstavros@mofo.com”

 

2.6Section 13 (Definitions).  The following term and its definition set forth in Section 13.1 is amended in its entirety and replaced with the following:

“Borrowing Base” is (a) eighty percent (80%) of Eligible Accounts, plus (b) eighty percent (80%) of Eligible Foreign Accounts (provided, however, Eligible Foreign Accounts that are billed in a Foreign Currency shall have an advance rate of seventy percent (70%); and provided, further, that to the extent Eligible Foreign Accounts include BASF Receivables, such calculation shall be net of any credits Borrower is required to provide to BASF in connection with the BASF Receivables due to each Pre-Payment pursuant to the Supply Agreement), provided, that, the availability under this subsection (b) plus the availability under subsection (c) below shall not exceed seventy-five percent (75%) of the Borrowing Base, plus (c) (i) when a Streamline Period is not in effect, the lesser of eighty percent (80%) of Eligible Specified Accounts or One Million Dollars ($1,000,000) and (ii) during a Streamline Period, eighty percent (80%) of Eligible Specified Accounts (and with respect to subsections (c)(i) and (c)(ii) hereof, when added to the availability under subsection (b) above, in each case subject to the overall cap set forth in subsection (b) above), as determined by Bank from Borrower’s most recent Borrowing Base Report (and as may subsequently be updated by Bank in Bank’s sole discretion based upon information received by Bank including, without limitation, Accounts that are paid and/or billed following the date of the Borrowing Base Report); provided, however, that Bank may decrease the foregoing amounts and percentages in its good faith business judgment based on events, conditions, contingencies, or risks which, as determined by Bank, may adversely affect the Collateral.

“LIBOR Rate Margin” is the rate per annum set forth under the relevant column heading below:

		
	
Borrowing Base Component
	
LIBOR Rate Margin during a Streamline Period

	
Eligible Accounts
	
3.75%

	
Eligible Foreign Accounts
	
4.25%

 

“Prime Rate Margin” is the rate per annum set forth under the relevant column heading below:

 

 

			
			
	
Borrowing Base Component
	
Prime Rate Margin during a Streamline Period
	
Prime Rate Margin when a Streamline Period is not in effect

	
Eligible Accounts
	
0.75%
	
1.50%

	
Eligible Foreign Accounts
	
1.25%
	
2.00%

 

“Revolving Line Maturity Date” is April 28, 2020.

 

2.7Section 13 (Definitions).  The following defined terms set forth in Section 13.1 is deleted in its entirety:

“Eligible Inventory” means Inventory that meets all of Borrower’s representations and warranties in Section 5.3 and is otherwise acceptable to Bank in all respects.

2.8Exhibit B (Compliance Certificate).  The Compliance Certificate attached to the Loan Agreement as Exhibit B is amended in its entirety and replaced with the Compliance Certificate in the form of Exhibit B attached hereto.

2.9Exhibit C (Form of Notice of Borrowing).  The Form of Notice of Borrowing attached to the Loan Agreement as Exhibit C is amended in its entirety and replaced with the Form of Notice of Borrowing in the form of Exhibit C attached hereto.

2.10Exhibit E (Borrowing Base Report).  The Borrowing Base Report attached to the Loan Agreement as Exhibit E is amended in its entirety and replaced with the Borrowing Base Report in the form of Exhibit E attached hereto.

	
3.
	
Limitation of Amendments.

3.1The amendments set forth in Section 2 above are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right or remedy which Bank may now have or may have in the future under or in connection with any Loan Document.

3.2This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents, except as herein amended, are hereby ratified and confirmed and shall remain in full force and effect.

4.Acknowledgement of Waiver.  Borrower and Bank acknowledge and agree that (i) the conditions set forth in the May Conditional Waiver with respect to the failure to comply with the Adjusted Quick Ratio financial covenant contained in former Section 6.9(b) of the Loan Agreement for the compliance period ending May 31, 2018 have been satisfied in full and the Resulting Default (as defined in the May Conditional Waiver) has been deemed waived by the Bank; and (ii) the conditions set forth in the August Conditional Waiver with respect to the failure to comply with each of (A) the Adjusted Quick Ratio financial covenant contained in former Section 6.9(b) of the Loan Agreement for the compliance periods ending August 31, 2018 and November 30, 2018 and (B) the EBITDA financial covenant contained in former Section 6.9(a) of the Loan Agreement for the compliance period ending December 31, 2018, in each case, have been satisfied in full and the Resulting Default (as defined in the August Conditional Waiver) has been deemed waived by the Bank.  Bank hereby acknowledges the effectiveness of its deemed waivers of the defaults described above.  Borrower hereby acknowledges and agrees that except as specifically provided herein or in the Conditional Waivers, nothing in this section or anywhere in this Agreement shall be deemed or otherwise construed as a waiver by Bank of any of its rights and remedies pursuant to the Loan Documents, applicable law or otherwise.

 

 

5.Representations and Warranties.  To induce Bank to enter into this Amendment, Borrower hereby represents and warrants to Bank as follows:

5.1Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing;

5.2Borrower has the power and authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement, as amended by this Amendment;

5.3The organizational documents of Borrower delivered to Bank on the Effective Date remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect;

5.4The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, have been duly authorized; 

5.5The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not and will not contravene (a) any law or regulation binding on or affecting Borrower, (b) any contractual restriction with a Person binding on Borrower, (c) any order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Borrower, or (d) the organizational documents of Borrower; 

5.6The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower, except as already has been obtained or made; and

5.7This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors’ rights.

6.Updated Perfection Certificate.  Borrower has delivered an updated Perfection Certificate dated as of March 1, 2019 (the “Updated Perfection Certificate”), which Updated Perfection Certificate shall supersede in all respects that certain Perfection Certificate dated as of April 25, 2018.  Borrower and Bank acknowledge and agree that all references in the Loan Agreement to the “Perfection Certificate” shall hereinafter be deemed to be a reference to the Updated Perfection Certificate.

7.No Defenses of Borrower.  Borrower hereby acknowledges and agrees that Borrower has no offsets, defenses, claims, or counterclaims against Bank with respect to the Obligations, or otherwise, and that if Borrower now has, or ever did have, any offsets, defenses, claims, or counterclaims against Bank, whether known or unknown, at law or in equity, all of them are hereby expressly WAIVED and Borrower hereby RELEASES Bank from any liability thereunder.

8. Integration.  This Amendment and the Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements.  All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of this Amendment and the Loan Documents merge into this Amendment and the Loan Documents.

9.Counterparts.  This Amendment may be executed in any number of counterparts and all of such 

 

 

counterparts taken together shall be deemed to constitute one and the same instrument.

10.Fees and Expenses.  Borrower agrees to promptly pay Bank, upon receipt of an invoice, Bank’s legal fees and expenses incurred in connection with this Amendment.   

11.Effectiveness.  As a condition precedent to the effectiveness of this Amendment and the Bank’s obligation to make further Advances under the Revolving Line, the Bank shall have received the following documents prior to or concurrently with this Amendment, each in form and substance reasonably satisfactory to Bank:

11.1this Amendment duly executed on behalf of Borrower;

11.2the Acknowledgment of Amendment and Reaffirmation of Guaranty substantially in the form attached hereto as Schedule 1, duly executed and delivered by Guarantor;

11.3Bank shall have received copies, certified by a duly authorized officer of Borrower, to be true and complete as of the date hereof, of each of the resolutions of Borrower authorizing the execution and delivery of this Amendment, the other documents executed in connection herewith and Borrower’s performance of all of the transactions contemplated hereby;

11.4a good standing certificate of Borrower and Guarantor, certified by the jurisdiction of incorporation of Borrower, dated as of a date no earlier than thirty (30) days prior to the date hereof;

11.5certified copies, dated as of a recent date, of financing statement and other lien searches of Borrower and Guarantor, as Bank may request and which shall be obtained by Bank, accompanied by written evidence (including any Uniform Commercial Code termination statements) that the Liens revealed in any such searched either (i) will be terminated prior to or in connection with this Amendment, or (ii) in the sole discretion of Bank, will constitute Permitted Liens;

11.6the Updated Perfection Certificate, duly executed by Borrower;

11.7Borrower’s payment of a fully earned, non-refundable amendment fee in the amount of Fifty Thousand Dollars ($50,000), payable in full on the date hereof; and

11.8such other documents as Bank may reasonably request.

12.Post-Closing Requirement.  Within thirty (30) days after the date of this Amendment, Borrower shall deliver to Bank evidence satisfactory to Bank that the insurance policies and endorsements required by Section 6.7 of the Loan Agreement are in full force and effect, together with appropriate evidence showing lender loss payable and/or additional insured clauses and cancellation notice to Bank (or endorsements reflecting same) in favor of Bank.  Failure to comply with the foregoing requirement within the time period noted, or such longer period as Bank may agree in its sole discretion, shall constitute an Event of Default for which no grace or cure period shall apply.

 

 

[Signature page follows.]

 

 

 

In Witness Whereof, the parties hereto have caused this Amendment to be duly executed and delivered as of the date first written above.

 

 

		
	
BANK
	
BORROWER

	
 

SILICON VALLEY BANK

 

 

By:  /s/ Megan Wood

Name: Megan Wood

Title:  Vice President
	
 

ASPEN AEROGELS, INC.

 

 

By:  /s/ John F. Fairbanks

Name: John F. Fairbanks

Title:  Chief Financial Officer

 

 

 

Schedule 1

 

ACKNOWLEDGMENT OF AMENDMENT
AND REAFFIRMATION OF GUARANTY

 

Section 1.Guarantor hereby acknowledges and confirms that it has reviewed and approved the terms and conditions of the Ninth Amendment to Amended and Restated Loan and Security Agreement dated as of the date hereof (“the “Amendment”).

 

Section 2.Guarantor hereby consents to the Amendment and agrees that the Guaranty relating to the Obligations of Borrower under the Loan Agreement shall continue in full force and effect, shall be valid and enforceable and shall not be impaired or otherwise affected by the execution of the Amendment or any other document or instruction delivered in connection herewith.

 

Section 3.Guarantor represents and warrants that, after giving effect to the Amendment, all representations and warranties contained in the Guaranty are true, accurate and complete as if made the date hereof.

 

Dated as of March 4, 2019.

 

	
GUARANTOR:
	
ASPEN AEROGELS RHODE ISLAND, LLC

 

 

By: /s/ John F. Fairbanks

 

Name: John F. Fairbanks

 

Title: Chief Financial Officer

 

 

EXHIBIT B

 

COMPLIANCE CERTIFICATE

 

TO:SILICON VALLEY BANKDate:  
FROM:  ASPEN AEROGELS, INC.

The undersigned authorized officer of Aspen Aerogels, Inc. (“Borrower”) certifies that under the terms and conditions of the Amended and Restated Loan and Security Agreement between Borrower and Bank (as amended and in effect, the “Agreement”), (1) Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below, (2) there are no Events of Default, (3) all representations and warranties in the Agreement are true and correct in all material respects on this date except as noted below; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date, (4) Borrower, and each of its Subsidiaries, has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section 5.9 of the Agreement, and (5) no Liens have been levied or claims made against Borrower or any of its Subsidiaries, if any, relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Bank.  Attached are the required documents supporting the certification.  The undersigned certifies that these are prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes.  The undersigned acknowledges that no borrowings may be requested at any time or date of determination that Borrower is not in compliance with any of the terms of the Agreement, and that compliance is determined not just at the date this certificate is delivered.  Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.

			
	
Please indicate compliance status by circling Yes/No under “Complies” column.

	
 

	
Reporting Covenant
	
Required
	
Complies

	
 
	
 
	
 

	
Monthly financial statements with 
Compliance Certificate
	
Monthly within 30 days
	
Yes   No

	
Quarterly financial statements
	
Quarterly within 45 days
	
Yes   No

	
Annual financial statement (CPA Audited) + CC
	
FYE within 150 days
	
Yes   No

	
10‐Q, 10‐K and 8-K
	
Within 5 days after filing with SEC
	
Yes   No

	
A/R & A/P Agings, and Deferred Revenue reports
	
Monthly within 20 days
	
Yes   No

	
Borrowing Base Reports
	
15th and last Business Day of each month (monthly within 20 days when 

a Streamline Period is in effect) and with each request for a

Credit Extension;

 
	
Yes   No

	
Projections
	
FYE within 30 days
	
Yes   No

	
 

	
The following Intellectual Property was registered after the Effective Date (if no registrations, state “None”)____________________________________________________________________________

 

				
	
Financial Covenant
	
Required
	
Actual
	
Complies

	
 
	
 
	
 
	
 

	
Maintain as indicated:
	
 
	
 
	
 

	
Minimum EBITDA
	
*
	
$
	
Yes   No

             *See Section 6.9

			
	
Performance Pricing
	
Applies

	
 
	
 
	
 

	
Adjusted Quick Ratio at least 1.50:1.00
	
Prime + 0.75% (Eligible Accounts) or Prime + 1.25% (Eligible Foreign Accounts); 

LIBOR + 3.75% (Eligible Accounts) or LIBOR +4.25% (Eligible Foreign Accounts)
	
Yes   No

	
Adjusted Quick Ratio less than 1.50:1.00
	
Prime + 1.50% (Eligible Accounts); Prime + 2.00% (Eligible Foreign Accounts)
	
Yes   No

 

 

 

 

 

The following financial covenant analyses and information set forth in Schedule 1 attached hereto are true and accurate as of the date of this Certificate.

 

The following are the exceptions with respect to the certification above: (If no exceptions exist, state “No exceptions to note.”)

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

		
	
ASPEN AEROGELS, INC.

 

By: 
Name: 
Title: 

	
BANK USE ONLY

 

Received by: _____________________
authorized signer

Date: _________________________

Verified: ________________________
authorized signer

Date: _________________________

Compliance Status:Yes     No

 

 

Schedule 1 to Compliance Certificate

 

Financial Covenants of Borrower

 

In the event of a conflict between this Schedule and the Loan Agreement, the terms of the Loan Agreement shall govern.

I.EBITDA (Section 6.9)

	
Required:
	
Borrower shall achieve, measured as of the end of each fiscal quarter during the following periods, EBITDA of at least (loss not worse than) the following for the following periods:

 

		
	
Period
	
Minimum EBITDA (maximum loss)

	
Trailing three (3) month period ending March 31, 2019
	
($4,500,000)

	
Trailing six (6) month period ending June 30, 2019
	
($5,000,000)

	
Trailing nine (9) month period ending September 30, 2019
	
($5,500,000)

	
Trailing twelve (12) month period ending December 31, 2019
	
($4,500,000)

 

 

Actual:

			
	
A.

 
	
Net Income
	
$

	
B.

 
	
To the extent included in the determination of Net Income
	
 

	
 
	
1.The provision for income taxes

 
	
$

	
 
	
2.Depreciation expense

 
	
$

	
 
	
3.Amortization expense

 
	
$

	
 
	
4.Net Interest Expense

 
	
$

	
 
	
5.Non-cash stock compensation expense

 
	
$

	
 
	
6.The sum of lines 1 through 5

 
	
$

	
C.
	
EBITDA (line A plus line B.6)

 
	
 

Is line C equal to or greater than $___________?

 

  No, not in compliance  Yes, in compliance

 

 

EXHIBIT C

FORM OF NOTICE OF BORROWING

Date:  ______________

To:  Silicon Valley Bank
3003 Tasman Drive
Santa Clara, CA  95054
Attention:  CFD Operations
Email:  CFDOperations@svb.com

Re:Amended and Restated Loan and Security Agreement dated as of September 3, 2014 (as amended, modified, supplemented or restated from time to time, the “Loan Agreement”), by and among ASPEN AEROGELS, INC., a Delaware corporation ( “Borrower”) and SILICON VALLEY BANK (the “Bank”)

Ladies and Gentlemen:

The undersigned refers to the Loan Agreement, the terms defined therein and used herein as so defined, and hereby gives you notice irrevocably, pursuant to Section 3.4(a) of the Loan Agreement, of the request for an Advance.

The Funding Date, which shall be a Business Day, of the requested borrowing is  _______, 201__.

The Currency of the requested borrowing is U.S. Dollars.

The aggregate amount of requested Advances is $.

The requested Advance is being requested with respect to [Eligible Accounts][Eligible Foreign Accounts].

The requested Advances shall consist of $___________ of Prime Rate Advances and $______ of LIBOR Advances.

The duration of the Interest Period for the LIBOR Advances included in the requested Advances shall be [one (1)][two (2)][three (3)] month(s).

The undersigned hereby certifies that the following statements are true on the date hereof, and will be true on the date of the proposed Credit Extension before and immediately after giving effect thereto, and to the application of the proceeds therefrom, as applicable:

(a)all representations and warranties of Borrower contained in the Loan Agreement are true, complete and correct in all material respects as of the date hereof; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date; and

(b)no Event of Default has occurred and is continuing, or would result from the disbursement of such proposed Credit Extension.

 

 

 

 

 

BORROWER:

	
	
ASPEN AEROGELS, INC.

 

By__________________________________
Name:_______________________________ 
Title:_______________________________

 

For internal Bank use only

				
	
LIBOR Pricing Date
	
LIBOR
	
LIBOR Variance
	
Maturity Date

	
 
	
 
	
____%
	
 

	
 
	
 
	
 
	
 

 

EXHIBIT E

 

BORROWING BASE REPORT

 

[To be provided by Bank]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}]]